Recent Publications

• Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report.
  Prestes-Carneiro Luiz Euribel, et al. Pathogens (Basel, Switzerland) 2023 0 0. (9)
  
• Hyperinflammatory Immune Response in COVID-19: Host Genetic Factors in Pyrin Inflammasome and Immunity to Virus in a Spanish Population from Majorca Island.
  Martínez-Pomar Natalia, et al. Biomedicines 2023 0 0. (9)
  
• Rare Variants in Primary Immunodeficiency Genes and Their Functional Partners in Severe COVID-19.
  Khadzhieva Maryam B, et al. Biomolecules 2023 0 0. (9)
  
• Evaluation of a Commercial Point-of-Care RT-LAMP Assay for Rapid Detection of SARS-CoV-2.
  Law Janet Hei Yin, et al. Biomedicines 2023 0 0. (9)
  
• Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients.
  Ovcar Eugen, et al. Vaccines 2023 0 0. (9)
  
• Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing.
  Bernardo Letizia, et al. Biology 2023 0 0. (9)
  
• Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study.
  Huang Yu-Tung, et al. Vaccines 2023 0 0. (9)
  
• The Rise and Fall of Omicron BA.1 Variant as Seen in Wastewater Supports Epidemiological Model Predictions.
  Liddor Naim Michal, et al. Viruses 2023 0 0. (9)
  
• Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities.
  Adimulam Theolan, et al. Genes 2023 0 0. (9)
  
• Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis.
  Giovanetti Marta, et al. Viruses 2023 0 0. (9)
  
• From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.
  Andre Mickensone, et al. Biology 2023 0 0. (9)
  
• Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
  Yau Kevin, et al. Nature communications 2023 0 0. (1) 6041
  
• Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.
  Liu Xiaoqiang, et al. EClinicalMedicine 2023 0 0. 102231
  
• Correlation between wastewater and COVID-19 case incidence rates in major California sewersheds across three variant periods.
  Rabe Angela, et al. Journal of water and health 2023 0 0. (9) 1303-1317
  
• Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy.
  Boelig Rupsa C, et al. Frontiers in immunology 2023 0 0. 1216410
  
• Unique SARS-CoV-2 Variants, Tourism Metrics, and B.1.2 Emergence in Early COVID-19 Pandemic: A Correlation Analysis in South Dakota.
  Nahian Ahmed, et al. International journal of environmental research and public health 2023 0 0. (18)
  
• Risk factors and drug efficacy for severe illness in hemodialysis patients infected with the Omicron variant of COVID-19.
  Wu Yan, et al. Kidney & blood pressure research 2023 0 0.
  
• Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study.
  Dickow Jannis, et al. PloS one 2023 0 0. (9) e0292017
  
• Use of whole genome sequencing to identify low-frequency mutations in SARS-CoV-2 patients treated with remdesivir.
  Kuganya Nirmalarajah et al. Influenza Other Respir Viruses 2023 9 (9) e13179
  
• A weapon to fight against pervasive Omicron: systematic actions transiting to pre-COVID normal.
  Wang Na, et al. Frontiers in public health 2023 0 0. 1204275